David K. Meyerholz
About
David K. Meyerholz has authored 261 papers that have received a total of 14.2k indexed citations.
This includes 83 papers in Pulmonary and Respiratory Medicine, 53 papers in Infectious Diseases and 52 papers in Epidemiology. The topics of these papers are Neonatal Respiratory Health Research (44 papers), SARS-CoV-2 and COVID-19 Research (43 papers) and Therapeutic Advances in Cystic Fibrosis Research (36 papers). David K. Meyerholz is often cited by papers focused on Neonatal Respiratory Health Research (44 papers), SARS-CoV-2 and COVID-19 Research (43 papers) and Therapeutic Advances in Cystic Fibrosis Research (36 papers) and collaborates with scholars based in United States, China and Germany. David K. Meyerholz's co-authors include Stanley Perlman, Paul B. McCray, David A. Stoltz, Michael J. Welsh and Mark R. Ackermann and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.
In The Last Decade
side by side view
Countries citing papers authored by David K. Meyerholz
Since SpecializationCitations
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Peter W. M. Hermans Breakdown of academic impact, for papers by Reza Shahbazian‐Yassar Breakdown of academic impact, for papers by R. Glyn Hewinson Breakdown of academic impact, for papers by Larry J. Siever Breakdown of academic impact, for papers by Susan M. Bögels Breakdown of academic impact, for papers by Mark van Kleunen Breakdown of academic impact, for papers by Philippa Easterbrook Breakdown of academic impact, for papers by Thomas M. Hyde